CareDx, Inc. (CDNA)
67.15
+0.92
(+1.39%)
USD |
NASDAQ |
Oct 02, 16:00
67.30
+0.15
(+0.22%)
After-Hours: 20:00
CareDx Enterprise Value : 3.103B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 3.103B |
| October 01, 2026 | 3.055B |
| September 30, 2026 | 2.992B |
| September 29, 2026 | 2.942B |
| September 28, 2026 | 2.971B |
| September 25, 2026 | 2.924B |
| September 24, 2026 | 2.805B |
| September 23, 2026 | 2.442B |
| September 22, 2026 | 2.554B |
| September 21, 2026 | 2.443B |
| September 18, 2026 | 2.417B |
| September 17, 2026 | 2.440B |
| September 16, 2026 | 2.402B |
| September 15, 2026 | 2.356B |
| September 14, 2026 | 2.342B |
| September 11, 2026 | 2.233B |
| September 10, 2026 | 2.221B |
| September 09, 2026 | 2.221B |
| September 08, 2026 | 2.236B |
| September 04, 2026 | 2.265B |
| September 03, 2026 | 2.213B |
| September 02, 2026 | 2.199B |
| September 01, 2026 | 2.167B |
| August 31, 2026 | 2.225B |
| August 28, 2026 | 2.209B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.341B |
| August 26, 2026 | 2.269B |
| August 25, 2026 | 2.261B |
| August 24, 2026 | 2.091B |
| August 21, 2026 | 2.148B |
| August 20, 2026 | 2.065B |
| August 19, 2026 | 2.040B |
| August 18, 2026 | 2.023B |
| August 17, 2026 | 2.033B |
| August 14, 2026 | 1.979B |
| August 13, 2026 | 2.085B |
| August 12, 2026 | 2.081B |
| August 11, 2026 | 2.077B |
| August 10, 2026 | 2.069B |
| August 07, 2026 | 2.049B |
| August 06, 2026 | 1.953B |
| August 05, 2026 | 1.988B |
| August 04, 2026 | 2.070B |
| August 03, 2026 | 2.109B |
| July 31, 2026 | 1.896B |
| July 30, 2026 | 1.607B |
| July 29, 2026 | 1.469B |
| July 28, 2026 | 1.486B |
| July 27, 2026 | 1.518B |
| July 24, 2026 | 1.558B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 58.08B |
| Caris Life Sciences, Inc. | 7.656B |
| Myriad Genetics, Inc. | 529.32M |
| BioRestorative Therapies, Inc. | -0.8314M |
| Exagen, Inc. | 200.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 110.64M |
| Revenue (Quarterly) | 131.95M |
| Total Expenses (Quarterly) | 21.31M |
| EPS Diluted (Quarterly) | 2.071 |
| Gross Profit Margin (Quarterly) | 73.37% |
| Profit Margin (Quarterly) | 83.85% |
| Earnings Yield | 3.09% |
| Normalized Earnings Yield | 3.148 |